Skip to main content

Table 3 Comparaison of clinicopathological features by germline BRCA1 c.5309G > T and BRCA2 c.1310_1313 DelAAGA mutations in female BC of northeastern Morocco

From: Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling

 

BRCA1 c.5309G>T mutation

BRCA2 c.1310_1313 DelAAGA mutation

Neg (n = 174)

Pos (n = 10)

 

Neg (n = 132)

Pos (n = 12)

 

Characteristics

n (%)

n (%)

pa

n (%)

n (%)

pa

Age at diagnosis

 Mean (years ± SD)

42.2 ± 9.62

41 ± 6.02

0.799

43.96 ± 9.89

38.5 ± 8.92

0.09

  ≤ 39

70 (41.9)

4 (40)

 

47 (37)

6 (60)

 

  > 39

97 (58.1)

6 (60)

1

80 (63)

4 (40)

0.185

 unknown

7

0

 

5

2

 

Family history of BCb

 Sporadic

91 (54.8)

1 (10)

 

74 (58.7)

3 (30)

 

 Familial

75 (45.2)

9 (90)

0.007

52 (41.3)

7 (70)

0.1

Laterality

 Bilateral

6 (3.6)

2 (20)

 

8 (6.3)

0 (0)

 

 Unilateral

161 (96.4)

8 (80)

0.067

119 (93.7)

10 (100)

1

Histological type

 Ductal invasive

140 (83.8)

8 (80)

 

108 (85)

8 (80)

 

 Lobular invasive

16 (9.6)

1 (10)

1

11 (8.7)

1 (10)

1

 others

11 (6.6)

1 (10)

0.51

8 (6.3)

1 (10)

0.5

Histological grade

 I + II

125 (75.3)

8 (80)

 

97 (77)

6 (60)

 

 III

41 (24.7)

2 (20)

1

29 (23)

4 (40)

0.256

RE

 Positive

120 (72.7)

6 (60)

 

89 (71.2)

8 (80)

 

 Negative

45 (27.3)

4 (40)

0.47

36 (28.8)

2 (20)

0.725

RP

 Positive

109 (66.1)

6 (60)

 

83 (66.4)

6 (60)

 

 Negative

56 (33.9)

4 (40)

0.74

42 (33.6)

4 (40)

0.735

Her-2

 Positive

34 (21.2)

0 (0)

 

24 (19.8)

0 (0)

 

 Negative

126 (78.8)

10 (100)

0.21

97 (80.2)

9 (100)

0.209

Sub-Type

 Luminal

97 (60.6)

5 (50)

Ref

75 (62)

7 (77.8)

Ref

 Her-2 + 

33 (20.6)

0 (0)

0.33

23 (19)

0 (0)

0.343

 Triple Negative

30 (18.8)

5 (50)

0.12

23 (19)

2 (22.2)

1

Tumor size

 T1

33 (20.2)

2 (22.2)

1

28 (22.8)

3 (30)

0.722

 T2

95 (58.3)

5 (55.6)

Ref

68 (55.3)

6 (60)

Ref

 T3-T4

35 (21.5)

2 (22.2)

1

27 (22)

1 (10)

0.67

Node

 N + 

120 (72.3)

5 (55.6)

 

87 (69.6)

9 (90)

 

 N0

46 (27.7)

4 (44.4)

0.28

38 (30.4)

1 (10)

0.28

Metastase

 M0

143 (86.1)

8 (80)

 

105 (82.7)

10 (100)

 

 M + 

23 (13.9)

2 (20)

0.64

22 (17.3)

0 (0)

0.365

  1. Neg Negative, Pos Positive, n (%) number and percentage of individuals (except for mean ± SD age), SD Standard deviation, Her-2 Human epidermal growth factor receptor-2, PR Progesterone receptor, ER Estrogen receptor, TN Triple negative
  2. Unknown data were excluded from statistical analysis
  3. abold values are statistically significant (P < 0.05). P (2 tailed)
  4. bboth mutations: p = 0.002